A review of health care models for coronary heart disease interventions

K Cooper1, S C Brailsford, R Davies

  • 1Wessex Institute for Health Research and Development, University of Southampton, Highfield, Southampton, Hants S016 7PX, UK. kc@soton.ac.uk

Insights

This review examines health intervention models for coronary heart disease (CHD) treatment. Incomplete reporting of model structures and assumptions limits confidence in results, necessitating more explicit documentation.

Area of Science:

  • Health economics
  • Epidemiological modeling
  • Health services research

Background:

  • Coronary heart disease (CHD) treatment involves complex decision-making.
  • Various modeling techniques are employed to assess treatment strategies, plan resources, and predict disease burden.
  • Existing models often have limitations in scope and reporting clarity.

Purpose of the Study:

  • To review and analyze modeling techniques used for coronary heart disease (CHD) interventions.
  • To discuss the assumptions, limitations, and applications of different modeling approaches.
  • To provide recommendations for improving the transparency and reliability of health economic models.

Main Methods:

  • Systematic review of published literature on CHD treatment models.
  • Categorization of models based on intervention type (acute vs. chronic) and methodology (decision trees, Markov models, discrete event simulation).
  • Analysis of model scope (cohort vs. population-based) and complexity (health states, system representation).

Main Results:

  • Decision tree and Markov models are common for short-term and long-term interventions, respectively.
  • Discrete event simulation is used for complex, resource-constrained systems.
  • Most reviewed models were cohort-based, limiting population-level cost-benefit analysis.
  • Model descriptions were frequently incomplete, hindering reproducibility and confidence.

Conclusions:

  • There is a need for more comprehensive reporting of model structure, assumptions, and input parameters in CHD research.
  • Explicit reporting enhances transparency, reduces bias, and increases confidence in model-derived results.
  • Standardized reporting guidelines could improve the quality and utility of health economic models for CHD interventions.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Models of Health Promotion and Illness Prevention I01:25

Models of Health Promotion and Illness Prevention I

A model is a theoretical way to understand a concept or an idea. Models can overcome barriers to health regardless of diverse economic and cultural backgrounds. In addition, models make the task easier by providing different ways to approach complex issues. There are two major health promotion models: the health belief model and the health promotion model.
The health belief model (HBM) attempts to predict health-related behavior in specific belief patterns. According to the HBM, a person's...
Models of Health Promotion and Illness Prevention II01:18

Models of Health Promotion and Illness Prevention II

The person's health status fluctuates continually, varying from being in good health to becoming ill and returning to being healthy. To understand the concept of illness prevention, there are two models. First, the health-illness continuum model is a graphic representation of an individual's wellness. It states that a person is considered healthy in the absence of physical disease and the presence of good emotional health.
The agent-host-environment model states that disease results from...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...